OncoDNA
The European biotech believes its bespoke, tumor-specific candidate could have advantages over personalized cancer vaccines that use mRNA and DNA.
OncoDNA, Eli Lilly Partner on Thyroid Cancer Biomarker Testing
The companies are working together to offer next-generation sequencing-based molecular testing on thyroid cancer biopsies to clinicians in Italy.
OncoDNA, Sophia Genetics Partner on Tumor Profiling
OncoDNA will customize its OncoKDM platform to work with Sophia's DDM genomic analytics platform to help cancer centers adopt large-panel genomic profiling.
Bayer, OncoDNA, Tamkin Al-Seha Medical Partner to Offer NTRK Fusion Testing in Saudi Arabia
The partnership aims to test 1,000 advanced cancer patients in the country to determine their eligibility for the TRK inhibitor larotrectinib.
OncoDNA, Institut Curie Partner on Liquid Biopsy Research in Head and Neck Cancer
The French cancer center will use OncoDNA's blood-based next-generation sequencing test, OncoFollow, in its ongoing SCANDARE study.